Ajax loader

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Merck

TAIWAN-CHIPS/
RTSB85SU 
September 14, 2022 
People sit next to a Merck logo at SEMICON Taiwan in Taipei, Taiwan, September 14, 2022. REUTERS/Ann... 
Taipei, Taiwan 
Semicon Taiwan opens in Taipei 
People sit next to a Merck logo at SEMICON Taiwan in Taipei, Taiwan, September 14, 2022. REUTERS/Ann Wang 
MUSIC-SONGWRITERS HALL OF FAME/
RTS8RC7Z 
June 16, 2022 
Merck Mercuriadis attends the Songwriters Hall of Fame 51st Annual Induction and Awards Gala in New York... 
New York, UNITED STATES 
The Songwriters Hall of Fame 51st Annual Induction Gala in New York City 
Merck Mercuriadis attends the Songwriters Hall of Fame 51st Annual Induction and Awards Gala in New York New York, U.S., June 16, 2022. REUTERS/Caitlin Ochs 
MERCK & CO-RESULTS/
RTXK6K3O 
November 17, 2021 
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City,... 
New York City, UNITED STATES 
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City... 
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, New York, U.S., November 17, 2021. REUTERS/Andrew Kelly 
MERCK & CO-RESULTS/
RTXK6K3K 
November 17, 2021 
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City,... 
New York City, UNITED STATES 
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City... 
The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, New York, U.S., November 17, 2021. REUTERS/Andrew Kelly 
MERCK & CO-RESULTS/
RTXJZ39U 
November 13, 2021 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew... 
Kenilworth, UNITED STATES 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew Kelly 
MERCK & CO-RESULTS/
RTXJZ39T 
November 13, 2021 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew... 
Kenilworth, UNITED STATES 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew Kelly 
MERCK & CO-RESULTS/
RTXJZ39S 
November 13, 2021 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew... 
Kenilworth, UNITED STATES 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew Kelly 
MERCK & CO-RESULTS/
RTXJZ39R 
November 13, 2021 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew... 
Kenilworth, UNITED STATES 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew Kelly 
MERCK & CO-RESULTS/
RTXJZ39Q 
November 13, 2021 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew... 
Kenilworth, UNITED STATES 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew Kelly 
MERCK & CO-RESULTS/
RTXJZ389 
November 13, 2021 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew... 
Kenilworth, UNITED STATES 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey 
Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew Kelly 
MILKEN-CONFERENCE/
RTXIQDDP 
October 18, 2021 
Julie Gerberding, Chief Patient Officer and Executive Vice President of Merck speaks at the 2021 Milken... 
Beverly Hills, UNITED STATES 
2021 Milken Institute Global Conference in Beverly Hills 
Julie Gerberding, Chief Patient Officer and Executive Vice President of Merck speaks at the 2021 Milken Institute Global Conference in Beverly Hills, California, U.S., October 18, 2021. REUTERS/David Swanson 
MILKEN-CONFERENCE/
RTXIQDCF 
October 18, 2021 
Julie Gerberding, Chief Patient Officer and Executive Vice President of Merck speaks at the 2021 Milken... 
Beverly Hills, UNITED STATES 
2021 Milken Institute Global Conference in Beverly Hills 
Julie Gerberding, Chief Patient Officer and Executive Vice President of Merck speaks at the 2021 Milken Institute Global Conference in Beverly Hills, California, U.S., October 18, 2021. REUTERS/David Swanson 
MILKEN-CONFERENCE/
RTXIQD4W 
October 18, 2021 
Julie Gerberding, Chief Patient Officer and Executive Vice President of Merck speaks at the 2021 Milken... 
Beverly Hills, UNITED STATES 
2021 Milken Institute Global Conference in Beverly Hills 
Julie Gerberding, Chief Patient Officer and Executive Vice President of Merck speaks at the 2021 Milken Institute Global Conference in Beverly Hills, California, U.S., October 18, 2021. REUTERS/David Swanson 
MILKEN-CONFERENCE/
RTXIQD4X 
October 18, 2021 
Julie Gerberding, Chief Patient Officer and Executive Vice President of Merck speaks at the 2021 Milken... 
Beverly Hills, UNITED STATES 
2021 Milken Institute Global Conference in Beverly Hills 
Julie Gerberding, Chief Patient Officer and Executive Vice President of Merck speaks at the 2021 Milken Institute Global Conference in Beverly Hills, California, U.S., October 18, 2021. REUTERS/David Swanson 
HEALTH-CORONAVIRUS/MERCK
RTXBZTQI 
May 04, 2021 
Merck KGaA CEO Belen Garijo and Hesse State Premier Volker Bouffier talk to employees of the medical... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
Merck KGaA CEO Belen Garijo and Hesse State Premier Volker Bouffier talk to employees of the medical service of the drugs and chemicals group Merck KGaA at their vacination centre in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/MERCK
RTXBZTQF 
May 04, 2021 
Company medical officer Katja Gilbert and Hesse State Premier Volker Bouffier visit employees of the... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
Company medical officer Katja Gilbert and Hesse State Premier Volker Bouffier visit employees of the medical service of the drugs and chemicals group Merck KGaA at the vaccination centre at Merck's plant in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/MERCK
RTXBZTNJ 
May 04, 2021 
Company medical officer Katja Gilbert and Hesse State Premier Volker Bouffier visit employees of the... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
Company medical officer Katja Gilbert and Hesse State Premier Volker Bouffier visit employees of the medical service of the drugs and chemicals group Merck KGaA at the vaccination centre at Merck's plant in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/MERCK
RTXBZTNH 
May 04, 2021 
Company medical officer Katja Gilbert and Hesse State Premier Volker Bouffier visit employees of the... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
Company medical officer Katja Gilbert and Hesse State Premier Volker Bouffier visit employees of the medical service of the drugs and chemicals group Merck KGaA at the vaccination centre at Merck's plant in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/MERCK
RTXBZTL7 
May 04, 2021 
Company medical officer Katja Gilbert and Hesse State Premier Volker Bouffier visit employees of the... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
Company medical officer Katja Gilbert and Hesse State Premier Volker Bouffier visit employees of the medical service of the drugs and chemicals group Merck KGaA at the vaccination centre at Merck's plant in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/MERCK
RTXBZTGE 
May 04, 2021 
Employees of the medical service of the drugs and chemicals group Merck KGaA wait in front of their vaccination... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
Employees of the medical service of the drugs and chemicals group Merck KGaA wait in front of their vaccination cabins at the vaccination centre at Merck's plant in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/MERCK
RTXBZTE2 
May 04, 2021 
An employee of the drugs and chemicals group Merck KGaA waits in line in front of a vaccination centre... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
An employee of the drugs and chemicals group Merck KGaA waits in line in front of a vaccination centre at Merck's plant in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/MERCK
RTXBZTDU 
May 04, 2021 
Employees of the drugs and chemicals group Merck KGaA wait in line in front of a vaccination centre at... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
Employees of the drugs and chemicals group Merck KGaA wait in line in front of a vaccination centre at Merck's plant in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/MERCK
RTXBZTAH 
May 04, 2021 
Employees of the drugs and chemicals group Merck KGaA wait in line near a syringe marker and the letters... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
Employees of the drugs and chemicals group Merck KGaA wait in line near a syringe marker and the letters "vaccination" in front of a vaccination centre at Merck's plant in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/MERCK
RTXBZTAG 
May 04, 2021 
An employee of the drugs and chemicals group Merck KGaA waits in line near a syringe marker and the letters... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
An employee of the drugs and chemicals group Merck KGaA waits in line near a syringe marker and the letters "vaccination" in front of a vaccination centre at Merck's plant in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/MERCK
RTXBZTAF 
May 04, 2021 
An employee of the drugs and chemicals group Merck KGaA waits in line near a syringe marker and the letters... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
An employee of the drugs and chemicals group Merck KGaA waits in line near a syringe marker and the letters "vaccination" in front of a vaccination centre at Merck's plant in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/MERCK
RTXBZTAE 
May 04, 2021 
An employee of the drugs and chemicals group Merck KGaA waits in line near a syringe marker and the letters... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
An employee of the drugs and chemicals group Merck KGaA waits in line near a syringe marker and the letters "vaccination" in front of a vaccination centre at Merck's plant in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/MERCK
RTXBZT3D 
May 04, 2021 
Employees of the drugs and chemicals group Merck KGaA wait in line in front of a vaccination centre at... 
Darmstadt, Germany 
COVID-19 vaccination centre at drugs and chemicals group Merck KGaA in Darmstadt 
Employees of the drugs and chemicals group Merck KGaA wait in line in front of a vaccination centre at Merck's plant in Darmstadt, Germany, May 4, 2021, as Germany started projects involving company doctors helping in the state's vaccination campaign against the coronavirus disease (COVID-19). Arne Dedert/Pool via REUTERS 
HEALTH-CORONAVIRUS/BIDEN
RTXAASHW 
March 10, 2021 
Johnson & Johnson CEO Alex Gorsky speaks after U.S. President Joe Biden announced administration plans... 
Washington, UNITED STATES 
U.S. President Biden hosts White House event on effort to produce more coronavirus vaccine in Washington... 
Johnson & Johnson CEO Alex Gorsky speaks after U.S. President Joe Biden announced administration plans to double its order of the single-shot Johnson & Johnson coronavirus vaccine, procuring an additional 100 million doses, as Biden and Merck CEO Kenneth Frazier listen during an event to discuss their partnership to produce additional vaccine in the South Court Auditorium at the White House in Washington, U.S., March 10, 2021. REUTERS/Tom Brenner 
HEALTH-CORONAVIRUS/BIDEN
RTXAAS9J 
March 10, 2021 
Johnson & Johnson CEO Alex Gorsky speaks after U.S. President Joe Biden announced administration plans... 
Washington, UNITED STATES 
U.S. President Biden hosts White House event on effort to produce more coronavirus vaccine in Washington... 
Johnson & Johnson CEO Alex Gorsky speaks after U.S. President Joe Biden announced administration plans to double its order of the single-shot Johnson & Johnson coronavirus vaccine, procuring an additional 100 million doses, during an event with Johnson & Johnson and Merck executives in the South Court Auditorium at the White House in Washington, U.S., March 10, 2021. REUTERS/Tom Brenner 
HEALTH-CORONAVIRUS/BIDEN
RTXAARZB 
March 10, 2021 
Merck CEO Kenneth Frazier speaks after U.S. President Joe Biden announced administration plans to double... 
Washington, UNITED STATES 
U.S. President Biden hosts White House event on effort to produce more coronavirus vaccine in Washington... 
Merck CEO Kenneth Frazier speaks after U.S. President Joe Biden announced administration plans to double its order of the single-shot Johnson & Johnson coronavirus vaccine, procuring an additional 100 million doses, during an event with Johnson & Johnson and Merck executives in the South Court Auditorium at the White House in Washington, U.S., March 10, 2021. REUTERS/Tom Brenner 
HEALTH-CORONAVIRUS/BIDEN
RTXAARNH 
March 10, 2021 
U.S. President Joe Biden announces administration plans to double its order of the single-shot Johnson... 
Washington, UNITED STATES 
U.S. President Biden hosts White House event on effort to produce more coronavirus vaccine in Washington... 
U.S. President Joe Biden announces administration plans to double its order of the single-shot Johnson & Johnson coronavirus vaccine, procuring an additional 100 million doses, during an event with Johnson & Johnson CEO Alex Gorsky and Merck CEO Kenneth Frazier in the South Court Auditorium at the White House in Washington, U.S., March 10, 2021. REUTERS/Tom Brenner 
HEALTH-CORONAVIRUS/BIDEN
RTXAARDP 
March 10, 2021 
U.S. President Joe Biden arrives to announce administration plans to double its order of the single-shot... 
Washington, UNITED STATES 
U.S. President Biden hosts White House event on effort to produce more coronavirus vaccine in Washington... 
U.S. President Joe Biden arrives to announce administration plans to double its order of the single-shot Johnson & Johnson coronavirus vaccine, procuring an additional 100 million doses, during an event with Johnson & Johnson CEO Alex Gorsky and Merck CEO Kenneth Frazier to discuss their partnership to produce more COVID-19 vaccines in the South Court Auditorium at the White House in Washington, U.S., March 10, 2021. REUTERS/Tom Brenner 
HEALTH-CORONAVIRUS/BIDEN
RTXAAQSM 
March 10, 2021 
U.S. President Joe Biden announces administration plans to double its order of the single-shot Johnson... 
Washington, UNITED STATES 
U.S. President Biden hosts White House event on effort to produce more coronavirus vaccine in Washington... 
U.S. President Joe Biden announces administration plans to double its order of the single-shot Johnson & Johnson coronavirus vaccine, procuring an additional 100 million doses, during an event with Johnson & Johnson CEO Alex Gorsky and Merck CEO Kenneth Frazier in the South Court Auditorium at the White House in Washington, U.S., March 10, 2021. REUTERS/Tom Brenner 
HEALTH-CORONAVIRUS/BIDEN
RTXAAQL6 
March 10, 2021 
U.S. President Joe Biden announces administration plans to double its order of the single-shot Johnson... 
Washington, UNITED STATES 
U.S. President Biden hosts White House event on effort to produce more coronavirus vaccine in Washington... 
U.S. President Joe Biden announces administration plans to double its order of the single-shot Johnson & Johnson coronavirus vaccine, procuring an additional 100 million doses, during an event with Johnson & Johnson CEO Alex Gorsky and Merck CEO Kenneth Frazier in the South Court Auditorium at the White House in Washington, U.S., March 10, 2021. REUTERS/Tom Brenner 
HEALTH-CORONAVIRUS/BIDEN
RTXAAQJQ 
March 10, 2021 
U.S. President Joe Biden announces administration plans to double its order of the single-shot Johnson... 
Washington, UNITED STATES 
U.S. President Biden hosts White House event on effort to produce more coronavirus vaccine in Washington... 
U.S. President Joe Biden announces administration plans to double its order of the single-shot Johnson & Johnson coronavirus vaccine, procuring an additional 100 million doses, during an event with Johnson & Johnson CEO Alex Gorsky and Merck CEO Kenneth Frazier to discuss their partnership to produce more COVID-19 vaccines in the South Court Auditorium at the White House in Washington, U.S., March 10, 2021. REUTERS/Tom Brenner 
HEALTH-CORONAVIRUS/BIDEN
RTXAAQBT 
March 10, 2021 
U.S. President Joe Biden as he announces administration plans to double its order of the single-shot... 
Washington, UNITED STATES 
U.S. President Biden hosts White House event on effort to produce more coronavirus vaccine in Washington... 
U.S. President Joe Biden as he announces administration plans to double its order of the single-shot Johnson & Johnson coronavirus vaccine, procuring an additional 100 million doses, during an event with Johnson & Johnson CEO Alex Gorsky and Merck CEO Kenneth Frazier to discuss their partnership to produce more COVID-19 vaccines in the South Court Auditorium at the White House in Washington, U.S., March 10, 2021. REUTERS/Tom Brenner 
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3FD4E 
June 23, 2020 
Merck Executive Vice President And Chief Patient Officer Julie Gerberding gives a remote opening statement... 
Washington, UNITED STATES 
U.S. Senate Health, Education, Labor, and Pensions Committee hearing to examine COVID-19, 'focusing on... 
Merck Executive Vice President And Chief Patient Officer Julie Gerberding gives a remote opening statement during a hearing to examine COVID-19, 'focusing on lessons learned to prepare for the next pandemic', on Capitol Hill in Washington, DC, U.S., June 23, 2020. Greg Nash/Pool via REUTERS 
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3FD47 
June 23, 2020 
Merck Executive Vice President And Chief Patient Officer Julie Gerberding gives a remote opening statement... 
Washington, UNITED STATES 
U.S. Senate Health, Education, Labor, and Pensions Committee hearing to examine COVID-19, 'focusing on... 
Merck Executive Vice President And Chief Patient Officer Julie Gerberding gives a remote opening statement during a hearing to examine COVID-19, 'focusing on lessons learned to prepare for the next pandemic', on Capitol Hill in Washington, DC, U.S., June 23, 2020. Greg Nash/Pool via REUTERS 
FRANCE-LEVOTHYROX/TRIAL
RTS28NUX 
December 03, 2018 
French lawyer Christophe Leguevaques sits at a table with files inside the court before the the start... 
Villeurbanne, France 
French lawyer Christophe Leguevaques sits with files inside the court before the the start of a trial... 
French lawyer Christophe Leguevaques sits at a table with files inside the court before the the start of a trial by more than four thousand Levothyrox plaintiffs as part of the civil class action against the Merck laboratory, in Villeurbanne, France, December 3, 2018. REUTERS/Emmanuel Foudrot *** Local Caption *** People drink this year's Beaujolais Nouveau, in Lyon 
FRANCE-LEVOTHYROX/TRIAL
RTS28NUN 
December 03, 2018 
French lawyer Christophe Leguevaques sits at a table with files inside the court before the the start... 
Villeurbanne, France 
French lawyer Christophe Leguevaques sits with files inside the court before the the start of a trial... 
French lawyer Christophe Leguevaques sits at a table with files inside the court before the the start of a trial by more than four thousand Levothyrox plaintiffs as part of the civil class action against the Merck laboratory, in Villeurbanne, France, December 3, 2018. REUTERS/Emmanuel Foudrot *** Local Caption *** People drink this year's Beaujolais Nouveau, in Lyon 
FRANCE-LEVOTHYROX/TRIAL
RTS28NU9 
December 03, 2018 
French lawyer Christophe Leguevaques sits at a table with files inside the court before the the start... 
Villeurbanne, France 
French lawyer Christophe Leguevaques sits with files inside the court before the the start of a trial... 
French lawyer Christophe Leguevaques sits at a table with files inside the court before the the start of a trial by more than four thousand Levothyrox plaintiffs as part of the civil class action against the Merck laboratory, in Villeurbanne, France, December 3, 2018. REUTERS/Emmanuel Foudrot *** Local Caption *** People drink this year's Beaujolais Nouveau, in Lyon 
FRANCE-LEVOTHYROX/TRIAL
RTS28NQR 
December 03, 2018 
French lawyer Christophe Leguevaques stands inside the court before the the start of a trial by more... 
Villeurbanne, France 
French lawyer Christophe Leguevaques stands inside the court before the the start of a trial by more... 
French lawyer Christophe Leguevaques stands inside the court before the the start of a trial by more than four thousand Levothyrox plaintiffs as part of the civil class action against the Merck laboratory, in Villeurbanne, France, December 3, 2018. REUTERS/Emmanuel Foudrot *** Local Caption *** People drink this year's Beaujolais Nouveau, in Lyon 
FRANCE-LEVOTHYROX/TRIAL
RTS28NQP 
December 03, 2018 
Files are seen inside the court before the the start of a trial by more than four thousand Levothyrox... 
Villeurbanne, France 
Files are seen inside the court before the the start of a trial by more than four thousand Levothyrox... 
Files are seen inside the court before the the start of a trial by more than four thousand Levothyrox plaintiffs as part of the civil class action against the Merck laboratory, in Villeurbanne, France, December 3, 2018. REUTERS/Emmanuel Foudrot *** Local Caption *** People drink this year's Beaujolais Nouveau, in Lyon 
FRANCE-LEVOTHYROX/TRIAL
RTS28NQH 
December 03, 2018 
French lawyer Christophe Leguevaques sits at a table with files inside the court before the the start... 
Villeurbanne, France 
French lawyer Christophe Leguevaques sits with files inside the court before the the start of a trial... 
French lawyer Christophe Leguevaques sits at a table with files inside the court before the the start of a trial by more than four thousand Levothyrox plaintiffs as part of the civil class action against the Merck laboratory, in Villeurbanne, France, December 3, 2018. REUTERS/Emmanuel Foudrot *** Local Caption *** People drink this year's Beaujolais Nouveau, in Lyon 
FRANCE-LEVOTHYROX/TRIAL
RTS28NQG 
December 03, 2018 
French lawyer Christophe Leguevaques looks at files inside the court before the the start of a trial... 
Villeurbanne, France 
French lawyer Christophe Leguevaques looks at files inside the court before the the start of a trial... 
French lawyer Christophe Leguevaques looks at files inside the court before the the start of a trial by more than four thousand Levothyrox plaintiffs as part of the civil class action against the Merck laboratory, in Villeurbanne, France, December 3, 2018. REUTERS/Emmanuel Foudrot *** Local Caption *** People drink this year's Beaujolais Nouveau, in Lyon 
FRANCE-LEVOTHYROX/TRIAL
RTS28NQ6 
December 03, 2018 
French lawyer Christophe Leguevaques stands inside the court before the the start of a trial by more... 
Villeurbanne, France 
French lawyer Christophe Leguevaques stands inside the court before the the start of a trial by more... 
French lawyer Christophe Leguevaques stands inside the court before the the start of a trial by more than four thousand Levothyrox plaintiffs as part of the civil class action against the Merck laboratory, in Villeurbanne, France, December 3, 2018. REUTERS/Emmanuel Foudrot *** Local Caption *** People drink this year's Beaujolais Nouveau, in Lyon 
FRANCE-LEVOTHYROX/TRIAL
RTS28NPX 
December 03, 2018 
French lawyer Christophe Leguevaques stands inside the court before the the start of a trial by more... 
Villeurbanne, France 
French lawyer Christophe Leguevaques stands inside the court before the the start of a trial by more... 
French lawyer Christophe Leguevaques stands inside the court before the the start of a trial by more than four thousand Levothyrox plaintiffs as part of the civil class action against the Merck laboratory, in Villeurbanne, France, December 3, 2018. REUTERS/Emmanuel Foudrot *** Local Caption *** People drink this year's Beaujolais Nouveau, in Lyon 
FRANCE-LEVOTHYROX/TRIAL
RTS28NPQ 
December 03, 2018 
Files are seen inside the court before the the start of a trial by more than four thousand Levothyrox... 
Villeurbanne, France 
Files are seen inside the court before the the start of a trial by more than four thousand Levothyrox... 
Files are seen inside the court before the the start of a trial by more than four thousand Levothyrox plaintiffs as part of the civil class action against the Merck laboratory, in Villeurbanne, France, December 3, 2018. REUTERS/Emmanuel Foudrot *** Local Caption *** People drink this year's Beaujolais Nouveau, in Lyon 
FRANCE-LEVOTHYROX/TRIAL
RTS28NPJ 
December 03, 2018 
French lawyer Christophe Leguevaques looks a files inside the court before the the start of a trial by... 
Villeurbanne, France 
French lawyer Christophe Leguevaques looks at files inside the court before the the start of a trial... 
French lawyer Christophe Leguevaques looks a files inside the court before the the start of a trial by more than four thousand Levothyrox plaintiffs as part of the civil class action against the Merck laboratory, in Villeurbanne, France, December 3, 2018. REUTERS/Emmanuel Foudrot *** Local Caption *** People drink this year's Beaujolais Nouveau, in Lyon 
FRANCE-LEVOTHYROX/TRIAL
RTS28NP6 
December 03, 2018 
French lawyer Christophe Leguevaques speaks to journalists at the court before the the start of a trial... 
Villeurbanne, France 
French lawyer Christophe Leguevaques speaks to journalists at the court before the the start of a trial... 
French lawyer Christophe Leguevaques speaks to journalists at the court before the the start of a trial by more than four thousand Levothyrox plaintiffs as part of the civil class action against the Merck laboratory, in Villeurbanne, France, December 3, 2018. REUTERS/Emmanuel Foudrot *** Local Caption *** People drink this year's Beaujolais Nouveau, in Lyon 
SANTE-EBOLA/.FC
RTS289Q5 
November 30, 2018 
Le de´ploiement du vaccin rVSV-ZEBOV de´veloppe´ par Merck s’appuie sur la strate´gie de vaccination... 
Congo (DRC) 
Vacciner pour stopper Ebola.FC 
Le de´ploiement du vaccin rVSV-ZEBOV de´veloppe´ par Merck s’appuie sur la strate´gie de vaccination “en anneau”, qui s’appuie sur la liste des personnes ayant eu directement ou indirectement contact avec le patient infecte´. 
SOCCER-GERMANY-DAR-BCS/
RTX6H8GI 
October 31, 2018 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor,... 
Darmstadt, Germany 
DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor, Darmstadt, Germany - October 30, 2018 Hertha Berlin's Ondrej Duda in action REUTERS/Kai Pfaffenbach DFL regulations prohibit any use of photographs as image sequences and/or quasi-video - TPX IMAGES OF THE DAY 
SOCCER-GERMANY-DAR-BCS/
RTX6H7KK 
October 30, 2018 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor,... 
Darmstadt, Germany 
DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor, Darmstadt, Germany - October 30, 2018 SV Darmstadt 98's coach Dirk Schuster REUTERS/Kai Pfaffenbach DFL regulations prohibit any use of photographs as image sequences and/or quasi-video 
SOCCER-GERMANY-DAR-BCS/
RTX6H7KJ 
October 30, 2018 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor,... 
Darmstadt, Germany 
DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor, Darmstadt, Germany - October 30, 2018 Hertha Berlin's Vladimir Darida is shown a yellow card by referee Robert Kampka REUTERS/Kai Pfaffenbach DFL regulations prohibit any use of photographs as image sequences and/or quasi-video 
SOCCER-GERMANY-DAR-BCS/
RTX6H7KG 
October 30, 2018 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor,... 
Darmstadt, Germany 
DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor, Darmstadt, Germany - October 30, 2018 SV Darmstadt 98's Daniel Heuer Fernandes and Aytac Sulu look dejected after Maximilian Mittelstadt scored Hertha Berlin's second goal REUTERS/Kai Pfaffenbach DFL regulations prohibit any use of photographs as image sequences and/or quasi-video 
SOCCER-GERMANY-DAR-BCS/
RTX6H7K6 
October 30, 2018 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor,... 
Darmstadt, Germany 
DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor, Darmstadt, Germany - October 30, 2018 Hertha Berlin's Maximilian Mittelstadt celebrates scoring their second goal REUTERS/Kai Pfaffenbach DFL regulations prohibit any use of photographs as image sequences and/or quasi-video 
SOCCER-GERMANY-DAR-BCS/
RTX6H7K5 
October 30, 2018 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor,... 
Darmstadt, Germany 
DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor, Darmstadt, Germany - October 30, 2018 Hertha Berlin's Maximilian Mittelstadt scores their second goal REUTERS/Kai Pfaffenbach DFL regulations prohibit any use of photographs as image sequences and/or quasi-video 
SOCCER-GERMANY-DAR-BCS/
RTX6H7J9 
October 30, 2018 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor,... 
Darmstadt, Germany 
DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor, Darmstadt, Germany - October 30, 2018 Hertha Berlin coach Pal Dardai with Javairo Dilrosun REUTERS/Kai Pfaffenbach DFL regulations prohibit any use of photographs as image sequences and/or quasi-video 
SOCCER-GERMANY-DAR-BCS/
RTX6H7GQ 
October 30, 2018 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor,... 
Darmstadt, Germany 
DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor, Darmstadt, Germany - October 30, 2018 Hertha Berlin's Davie Selke in action with SV Darmstadt 98's Aytac Sulu REUTERS/Kai Pfaffenbach DFL regulations prohibit any use of photographs as image sequences and/or quasi-video 
SOCCER-GERMANY-DAR-BCS/
RTX6H7GD 
October 30, 2018 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor,... 
Darmstadt, Germany 
DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC 
Soccer Football - DFB Cup Second Round - SV Darmstadt 98 v Hertha BSC - Merck-Stadion am Bollenfalltor, Darmstadt, Germany - October 30, 2018 Hertha Berlin's Vedad Ibisevic celebrates scoring their first goal with team mates REUTERS/Kai Pfaffenbach DFL regulations prohibit any use of photographs as image sequences and/or quasi-video 
Sort by 
Display 
Items per page 
Page 
of 8